期刊文献+

肿瘤标志物联合检测诊断恶性胸腔积液的应用价值 被引量:6

Value of tumor markers combined detection in diagnosis of malignant pleural effusion
下载PDF
导出
摘要 目的探讨联合检测胸腔积液中CEA、CA15-3、CA19-9、β-HCG、TPA5种肿瘤标志物对鉴别诊断良恶性胸腔积液的价值。方法采用化学发光法检测恶性组、结核组和良性组患者胸腔积液中CEA、CA15-3、CA19-9、β-HCG、TPA的含量;并与CT和脱落细学检查进行比较,分析肿瘤标志物的诊断敏感性、特异性及其临床应用价值。结果恶性组胸腔积液中CEA、CA19-9、CA15-3、β-HCG含量明显高于结核组、良性组(P<0.01),其阳性检出率分别为:52.83%、47.17%、41.51%、43.40%;TPA在恶性组和结核组含量显著升高,明显高于良性组(P<0.01),TPA与任一项肿瘤标志物同时阳性诊断恶性胸腔积液敏感性为84.9%,特异性为87.69%,与CT和脱落细胞联合检测相当。结论胸腔积液中肿瘤标志物联合检测是CT和脱落细胞检查的有益补充,对恶性胸腔积液诊断具有良好的临床应用价值。 Objective To explore the value of the combined detection of carcino-embryonic antigen(CEA),CA15-3,CA19-9,β-human chorionic gonadotropin(β-HCG) and tissue polypeptide antigen(TPA) in pleural fluid for the differential diagnosis of malig-nant and benign pleural effusion. Methods The value of CEA,CA15-3,CA19-9,β-HCG and TPA in the pleural fluid were assayed by chemoluminescence method. The diagnostic sensitivity and specificity were analyzed through comparing with CT and exfoliated cells examination. Results The value of CEA,CA15-3,CA19-9 and β-HCG in malignant group were significantly higher than TB group and benign group(P〈0.01) ,their positive rates were 52.83% ,47.17% ,41.51% and 43.40%. The value of TPA in malig-nant group and TB group were increased significantly compared with benign group(P〈0.01). The sensitivity of TPA with either of other tumor markers in diagnosis of malignant pleural effusion was 84.9 %, and the specificity was 87.69%, which were similar with CT and exfoliated cells combined examinations. Conclusion These tumor markers might be useful for the diagnosis of malig- nant pleural effusion.
出处 《国际检验医学杂志》 CAS 2013年第4期415-417,420,共4页 International Journal of Laboratory Medicine
关键词 胸腔积液 肿瘤标记 生物学 体层摄影术 X线计算机 细胞诊断学 pleural effusion tumor markers,biological Tomography,X-Ray Computed cytodiagnosis
  • 相关文献

参考文献11

  • 1Hackbarth JS,Murata K,Reilly WM. Performance of CEA and CA19-9 in identifying pleural effusions caused by specific malignancies[J].Clinical Biochemistry,2010,(13-14):1051-1055.
  • 2Wagner IC,Guimaraes MJ,Da SL. Evaluation of serum and pleural levels of the tumor markers CEA,CYFRA21-1 and CA 15-3 in patients with pleural effusion[J].J Bras Pneumol,2007,(02):185-191.
  • 3Porcel JM,Vives M,Esquerda A. Use of a panel of tumor markers(carcinoembryonic antigen,cancer antigen 125,carbohydrate antigen 15-3,and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions[J].Chest,2004,(06):1757-1763.
  • 4Sthaneshwar P,Yap SF,Jayaram G. The diagnostic usefulness of tumour markers CEA and CA-125 in pleural effusion[J].Malaysian Journal of Pathology,2002,(01):53-58.
  • 5Shitrit D,Zingerman B,Shitrit AB. Diagnostic value of CYFRA 21-1,CEA,CA 19-9,CA 15-3,and CA 125 assays in pleural effusions:analysis of 116 cases and review of the literature[J].Oncologist(The),2005,(07):501-507.
  • 6Terracciano D,Mazzarella C,Cicalese M. Diagnostic value of carbohydrate antigens in supernatants and sediments of pleural effusions[J].Oncol Lett,2010,(03):465-471.
  • 7龙欣,唐荣斌,刘永兵.多种肿瘤标志物联合检测在肺癌诊断中的临床应用[J].国际检验医学杂志,2012,33(1):101-102. 被引量:20
  • 8Parazzi F,Faravelli B,Gallo L. Tissue polypeptide antigen(TPA) in pleural effusions[J].Tumori,1987,(01):33-36.
  • 9Radjenovic-Petkovic T,Pejcic T,Nastasijevic-Borovac D. Diagnostic value of CEA in pleural fluid for differential diagnosis of benign and malign pleural effusion[J].Medicinski Arhiv,2009,(03):141-142.
  • 10牛继国,呼永华,董峰,梅澍,赵瑞萍,包晓玲,曾贤伍,李文燕,达选祯.四项肿瘤标记物在肺癌中的表达及其相关因素分析[J].国际检验医学杂志,2011,32(20):2330-2333. 被引量:18

二级参考文献30

共引文献35

同被引文献69

引证文献6

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部